Managing Skeletal-Related Events in Breast Cancer, Part I

Panelists: William J. Gradishar, MD, Northwestern;Joyce O’Shaughnessy, MD, Texas Oncology;
Christy A. Russell, MD, USC Norris; Debu Tripathy, MD, USC Norris;
Linda Vahdat, MD, Weill Cornell Medical College
Published Online: Monday, December 3, 2012
For High-Definition, Click
Skeletal-related events (SREs) are common when administering both hormonal therapy and chemotherapy for patients with breast cancer. In recent years, several new treatment options have been approved that significantly help reduce SREs and improve quality of life.

Joyce A. O’Shaughnessy, MD, discusses results from clinical trials that compared the RANK ligand inhibitor denosumab to zoledronic acid in several tumor types. Overall, in metastatic breast cancer, denosumab showed superiority at reducing the occurrence of SREs. O'Shaughnessy explains that both these treatments are reasonable options but that she prefers denosumab for patients with newly diagnosed bone metastases or those progressing on IV bisphosphonates.

Christy A. Russell, MD, notes that a shortcoming of these trials is a lack of long-term data. Additionally, she feels the dosing schedule can be improved upon further. Moderator, Debu Tripathy, MD, believes that translating these agents into the early stage setting is one of the biggest challenges facing researchers.

View >>> Managing Skeletal-Related Events in Breast Cancer, Part II
View More From This Discussion
Episode 1 Improving the Management of Metastatic Breast Cancer, Part I
Episode 2 Management of Metastatic Breast Cancer, Part II
Episode 3 Chemotherapy in Advanced Breast Cancer
Episode 4 Emerging Therapies in Metastatic Breast Cancer
Episode 5 Managing Skeletal-Related Events in Breast Cancer, Part I
Episode 6 Managing Skeletal-Related Events in Breast Cancer, Part II
Episode 7 Molecular and Personalized Medicine in Breast Cancer
Expert Panelists
Debu Tripathy

Debu Tripathy, MD

Moderator
Co-Leader, Women's Cancer Program
USC Norris Comprehensive Cancer Center
University of Southern California
Los Angeles, California
 

William J. Gradishar, MD

Director, Maggie Daley Center
for Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Joyce A. O’Shaughnessy, MD

Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology, PA/US Oncology,
Dallas, Texas
 

Christy A. Russell, MD

Co-Director, USC Norris Breast Center
USC Norris Comprehensive Cancer Center
University of Southern California
Los Angeles, California

Linda T. Vahdat, MD

Director, Breast Cancer Research Program
Head, Solid Tumor Service
Weill Cornell Medical College
New York, New York
Online CME Activities
Free CME from PER
Community Practice Connections: 13th Annual International Congress on the Future of Breast Cancer®
Highlights From the 13th Annual International Congress on the Future of Breast Cancer®
Pancreatic Cancer: Novel and Emerging Approaches to Early Detection and Treatment
Oncology Best Practice: Challenges in Treating Chronic Lymphocytic Leukemia – The Older Patient and Comorbid Conditions
The content contained in this video is for general information purposes only. The viewer is encouraged to confirm the information presented with other sources. OncLiveTV Peer Exchange makes no representations or warranties of any kind about the completeness, accuracy, timeliness, reliability, or suitability of any of the information, including content or advertisements, contained in this video and expressly disclaims liability for any errors and omissions that may be presented in this video. OncLiveTV Peer Exchange reserves the right to alter or correct any error or omission in the information it provides in this video, without any obligations. OncLiveTV Peer Exchange further disclaims any and all liability for any direct, indirect, consequential, special, exemplary, or other damages arising from the use or misuse of any material or information presented in this video. The views expressed in this video are those of the panelists and do not necessarily reflect the opinion or policy of OncLiveTV Peer Exchange.
 
More Reading
$auto_registration$